from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2115c/mpa

LFCtreatmentdescriptionclass of inhibitor

-0.341

Amikacinug/mL Amikacintranslation

-0.015

Cap5-10ug/mL Capreomycintranslation

-0.415

Rox10-50 ug/mL Roxithromycintranslation

-0.424

SM2-5 ug/mL Streptomycintranslation

-0.823

Tet5-10 ug/mL Tetracyclinetranslation

-1.241

Rif0.2-5ug/mL Rifampicintranscription

-0.176

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.666

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.678

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.916

CPZ10-50 ug/mL Chlorpromazinerespiration

0.547

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.036

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.670

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.203

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.507

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.480

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.122

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.483

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.253

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.001

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.337

KCN5-20 ug/mL Potassium cyaniderespiration

0.322

NaN30.2-2 mM Sodium aziderespiration

0.311

Nigericin50 uM Nigericinrespiration

0.826

TRC10-150 ug/mL Triclosanrespiration

1.577

TRZ10-25 ug/mL Thioridazinerespiration

-0.294

Valinomycin0.5-10 uM Valinomycinrespiration

0.593

ZnSO42 mM ZnSO4respiration

1.430

menadione6-10 ug/mL Menadionerespiration

0.329

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.598

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.268

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.112

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.709

NRP_1Non-replicating persistence stage 1dosRassociated

0.206

Amp0.2mg/mL AmpicillincellWall

-0.128

Cephalexin20-100 ug/mL CephalexincellWall

-0.484

Cerulenin0.32-5 ug/mL CerulenincellWall

0.029

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.172

EMB10-20 ug/mL EthambutolcellWall

0.031

Eta12-40 ug/mL EthionamidecellWall

-0.354

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.115

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.473

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.752

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.518

BZA0.12 mg/mL BenzamidearomaticAmides

-0.771

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.884

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.424

H2O24 mM hydrogen peroxideDNAdamaging

-0.407

Levo10 ug/mL LevofloxacinDNAdamaging

-1.045

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.928

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.351

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.048

UVUV-irradiationDNAdamaging

-0.195

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.624

Antimycin12.5-50 ug/mL Antimycin A?

-0.219

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.222

PA_110-50 ug/mL Antitubercular compound PA-1?

0.004

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.077

PA8240.2-2 ug/mL PA-824?

-0.088

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.549

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.631

Verapamil50 uM Verapamil?

-0.268

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.456

methoxatin10-20 ug/mL Methoxatin?